Glucocorticoid (GC) — Competitive Intelligence Brief

Glucocorticoid (GC) (Glucocorticoid (GC)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glucocorticoid. Area: Immunology, Rheumatology, Endocrinology.

marketed Glucocorticoid Glucocorticoid receptor (GR) Immunology, Rheumatology, Endocrinology Small molecule

Target snapshot

Glucocorticoid (GC) (Glucocorticoid (GC)) — First Affiliated Hospital of Zhejiang University. Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene transcription.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Glucocorticoid (GC) TARGET	Glucocorticoid (GC)	First Affiliated Hospital of Zhejiang University	marketed	Glucocorticoid	Glucocorticoid receptor (GR)
Medrol	methylprednisolone	Generic (originally Upjohn/Pfizer)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor	1957-10-01
Prelone	prednisolone	Generic (originally Schering)	marketed	Glucocorticoid (corticosteroid)	Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1	1955-01-01
Methylprednisolone, prednisone	Methylprednisolone, prednisone	Medical University of Lodz	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Systemic dexamethasone	Systemic dexamethasone	Zealand University Hospital	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)
Methylprednisolone/prednisolone	Methylprednisolone/prednisolone	Chong Kun Dang Pharmaceutical	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Steroid Drug (prednisolone)	Steroid Drug (prednisolone)	Lumbini Medical College	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glucocorticoid class)

1. Research in Real-Life Ltd · 2 drugs in this class
2. NICHD Neonatal Research Network · 2 drugs in this class
3. UMC Utrecht · 2 drugs in this class
4. University of Pennsylvania · 2 drugs in this class
5. First Affiliated Hospital of Zhejiang University · 1 drug in this class
6. GlaxoSmithKline · 1 drug in this class
7. ClinAmygate · 1 drug in this class
8. Instituto de Investigación Sanitaria y Biomédica de Alicante · 1 drug in this class
9. First Affiliated Hospital of Wenzhou Medical University · 1 drug in this class
10. Guangzhou JOYO Pharma Co., Ltd · 1 drug in this class